Clinical Trial Update: IV Ketorolac on Platelet Function Post-Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the impact of intravenous ketorolac on platelet function after cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders
• Postoperative Pain
• Postpartum Hemorrhage

Drugs mentioned

• Ketorolac (Toradol) (Ketorolac)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Analgesia, Obstetrical, Coagulation Defect; Postpartum | Phase 4 | Status: COMPLETED